BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 34263641)

  • 21. Development and Validation of Prognostic Nomograms to Predict Overall and Cancer-Specific Survival for Patients with Adenocarcinoma of the Urinary Bladder: A Population-Based Study.
    Yang Z; Bai Y; Liu M; Hu X; Han P
    J Invest Surg; 2022 Jan; 35(1):30-37. PubMed ID: 32851885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
    Liu J; Lyu Y; He Y; Ge J; Zou W; Liu S; Yang H; Li J; Jiang K
    J Endocrinol Invest; 2024 Jun; 47(6):1545-1557. PubMed ID: 38170396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomograms that predict the survival of patients with adenocarcinoma in villous adenoma of the colorectum: a SEER-based study.
    Tang CT; Zeng L; Yang J; Zeng C; Chen Y
    BMC Cancer; 2020 Jun; 20(1):608. PubMed ID: 32600342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
    Chen Q; Wang S; Lang JH
    J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients.
    Chen L; Chen Y; Shi H; Cai R
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17027-17037. PubMed ID: 37747524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.
    Zheng P; Lai C; Yang W; Guo J; Xiao S; Chen Z
    Scand J Gastroenterol; 2020 Feb; 55(2):202-208. PubMed ID: 32008420
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma.
    Song Z; Cheng L; Lu L; Lu W; Zhou Y; Wang Z
    Front Endocrinol (Lausanne); 2021; 12():764571. PubMed ID: 35308782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development and Evaluation of Prognostic Nomogram Model for Adult Ventricle Glioma Patients].
    Zhang HD; Niu XD; Zhou XW; Yang Y; Li JM; Gan YJ; Wang X; Liu YH; Mao Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):588-596. PubMed ID: 35871728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
    Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
    Front Public Health; 2022; 10():969030. PubMed ID: 36203704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of prognostic nomogram for lung cancer patients below the age of 45 years.
    Dai L; Wang W; Liu Q; Xia T; Wang Q; Chen Q; Zhu N; Cheng Y; Yan Y; Shu J; Qu K
    Bosn J Basic Med Sci; 2021 Jun; 21(3):352-363. PubMed ID: 33091332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and Verification of Prognostic Nomograms for Patients with Gastrointestinal Stromal Tumors: A SEER-Based Study.
    Chen Z; Lin RM; Bai YK; Zhang Y
    Biomed Res Int; 2019; 2019():8293261. PubMed ID: 31032364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
    Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
    Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
    Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
    BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma.
    Jin H; Feng Y; Guo K; Ruan S
    Front Oncol; 2020; 10():595354. PubMed ID: 33194760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
    Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
    BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomograms to Predict Overall and Cancer-Specific Survival in Gastric Signet-Ring Cell Carcinoma.
    Chen CL; Xue DX; Chen HH; Liang MZ; Lin DZ; Yu M; Chen JX; Wu WL
    J Surg Res; 2021 Oct; 266():13-26. PubMed ID: 33979736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis.
    Wang X; Xu Y; Xu J; Chen Y; Song C; Jiang G; Chen R; Mao W; Zheng M; Wan Y
    Transl Cancer Res; 2023 Apr; 12(4):804-827. PubMed ID: 37180650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.